Atlas Trials

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

Clinical trial NCT05879757 · RECRUITING

Trial details

NCT number
NCT05879757
Sponsor
Takeda
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple MyelomaSecondary Immunodeficiency (SID)
Start date
2023-10-17
Primary completion
2027-02-16
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.